Neuralink’s New Trial to Assist Speech Impairments
Billionaire Elon Musk’s company, Neuralink, is preparing to start a new trial in October focused on helping individuals with speech impairments. This innovative approach aims to allow these individuals to convert their thoughts into text directly from their brains, bypassing the need for any keyboards.
Dongjin “D.J.” Seo, the president of Neuralink, shared this exciting news at an event in Seoul. The study aims to assist those who have lost their ability to speak, giving them a way to communicate more effectively. “If you’re imagining saying something, we would be able to pick that up,” he explained.
Recently, Neuralink announced that the U.S. Food and Drug Administration (FDA) has granted its brain implant a Breakthrough Device designation, which can speed up the testing and approval process. This is a significant milestone for the company, which began human trials in 2024 after addressing safety concerns that had led to a previous application denial in 2022.
As of last month, a total of 12 individuals around the world have received Neuralink’s chip and have logged over 15,000 hours of device use. The implant aims to assist people with severe conditions, including spinal cord injuries. One of the first chip users has reportedly played video games, browsed the internet, posted on social media, and moved a cursor on a laptop, showcasing its potential.
Neuralink’s commitment to helping those with disabilities is clear as they forge ahead in the rapidly advancing field of brain-computer interfaces. Competing company Synchron Inc. is also testing a similar implant to assist individuals with motor impairments in typing on computers.
As technology continues to bridge gaps in communication and control, the future looks promising for individuals seeking new ways to interact with the world around them.
